Journal profile · Peripheral Vascular Disease
Coronary Artery Disease
ISSN 0954-6928 · eISSN 1473-5830 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1990
Coronary Artery Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.06; JCR Q3 (journal website); hybrid open access; median 74 days to acceptance (46 articles, last 24 months); community-reported acceptance: easy; 120 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Coronary Artery Disease is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics and Acute Myocardial Infarction Research, together about 49.1% of its articles. Its main subfields are Surgery and Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease is technically demanding if there is a concomitant chronic total occlusion (CTO) of the right coronary artery (RCA). Which vessel to be revascularized in first attempt was not evaluated before.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Shih-Hsien SungPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Coronary Interventions and DiagnosticsMedicine18.3%
- Cardiac Imaging and DiagnosticsMedicine17.1%
- Acute Myocardial Infarction ResearchMedicine13.7%
- Cardiovascular Function and Risk FactorsMedicine4.6%
- Coronary Artery AnomaliesMedicine3.6%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine3.5%
- Cerebrovascular and Carotid Artery DiseasesMedicine2.9%
- Peripheral Artery Disease ManagementMedicine2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · CARDIAC & CARDIOVASCULAR SYSTEMS · rank 132/237
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.06LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 2.5LetPub ·
- SJR 2026-06
- 0.46LetPub ·
- SNIP 2026-06
- 0.72LetPub ·
- h-index
- 58LetPub ·
- h-index
- 79OpenAlex ·
- i10-index
- 1,507OpenAlex ·
- 2-year mean citedness
- 1.5OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 19.47%LetPub ·
Volume
- Articles per year
- 89LetPub ·
Articles by year OpenAlex count · 4,069 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 76 | 6 | 7 |
| 2025 | 120 | 16 | 98 |
| 2024 | 166 | 27 | 437 |
| 2023 | 101 | 24 | 590 |
| 2022 | 99 | 18 | 433 |
| 2021 | 117 | 18 | 687 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
74 daysMedian, submission to acceptance · P25–P75 48 days – 124 days
- Acceptance to online
- median 18 days (46 articles)
- Submission to online
- median 92 days
- Sample
- 46 articles with submission and acceptance dates (260 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1990
- ISSN
- 0954-6928
- Electronic ISSN
- 1473-5830
- Latest issue on the website
- Volume 37, Issue 6 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Coronary Artery Disease
What CAS zone is Coronary Artery Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Coronary Artery Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Coronary Artery Disease?
The latest impact factor listed by LetPub is 2.06; CiteScore 2.5, h-index 79.
How long does peer review take at Coronary Artery Disease?
Based on the dates recorded on 46 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 74 days (interquartile range 48–124 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Coronary Artery Disease in?
The journal's website gives JCR Q3; by category, CARDIAC & CARDIOVASCULAR SYSTEMS Q3 (132/237). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Coronary Artery Disease?
According to LetPub and DOAJ records, Coronary Artery Disease is indexed in SCIE and Scopus.
Is Coronary Artery Disease open access, and what is the APC?
Coronary Artery Disease is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .